<DOC>
	<DOCNO>NCT02725060</DOCNO>
	<brief_summary>The purpose study see people postural tachycardia syndrome ( POTS ) high level immune protein ( autoantibody ) direct receptor autonomic nervous system , autoantibody make difference POTS symptom . The investigator also want see level autoantibody stay time .</brief_summary>
	<brief_title>Autoimmune Basis Postural Tachycardia Syndrome</brief_title>
	<detailed_description>Postural tachycardia syndrome ( POTS ) debilitate disorder result cardiovascular autonomic dysfunction , many cause difficult treat effectively . The investigator identify presence autoantibody ( immune protein ) direct receptor autonomic nervous system cause patient 's symptom stand . The present study design test hypothesis patient POTS harbor functional autoantibody adrenergic receptor lead excessive tachycardia characteristic POTS . For purpose , study define prevalence , burden , vivo physiological significance adrenergic antibody well-phenotyped representative cohort patient POTS match cohort healthy control subject , characterize stability autoantibody time affected POTS patient .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Nervous System Diseases</mesh_term>
	<mesh_term>Arrhythmias , Cardiac</mesh_term>
	<mesh_term>Postural Orthostatic Tachycardia Syndrome</mesh_term>
	<mesh_term>Orthostatic Intolerance</mesh_term>
	<mesh_term>Primary Dysautonomias</mesh_term>
	<mesh_term>Autonomic Nervous System Diseases</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Isoproterenol</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Autoantibodies</mesh_term>
	<criteria>1850 year old Postural Tachycardia Syndrome : Heart rate increase &gt; 30 bpm supine within 10 min standing , absence orthostatic hypotension ( &gt; 20/10 mmHg fall blood pressure ) , chronic symptom ( &gt; 6 month ) , absence acute cause orthostatic tachycardia . Able willing provide inform consent Female premenopausal subject must utilize adequate birth control willingness undergo serum betahCG test The subject must understand able comply study procedure restriction . Hypertension ( &gt; 150 mmHg systolic &gt; 100 mmHg diastolic ) base history finding screen . Orthostatic hypotension ( consistent drop blood pressure &gt; 20/10 mmHg 10 min stand ) Pregnancy Cardiovascular disease , myocardial infarction within 6 month , angina pectoris , significant arrhythmia ( sinus tachycardia exclude ) , deep vein thrombosis , pulmonary embolism History serious neurologic disease History presence significant immunological hematological disorder Clinically significant gastrointestinal impairment could interfere dietary compliance drug absorption Impaired hepatic function ( aspartate amino transaminase and/or alanine amino transaminase &gt; 1.5 x upper limit normal range ) Impaired renal function ( serum creatinine &gt; 1.5 mg/dL ) Hematocrit &lt; 28 % Current concurrent disease could affect absorption , action disposition drug , clinical laboratory assessment . Any underlying acute disease require regular medication could possibly pose threat subject make implementation protocol interpretation study result difficult Inability comply protocol Healthy control subject healthy , nonsmoking chronic medication time study . Healthy control subject groupmatched POTS patient age gender . We attempt study female patient first half menstrual cycle minimize cyclical variability .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>POTS</keyword>
	<keyword>Orthostatic Intolerance</keyword>
	<keyword>Orthostatic Tachycardia</keyword>
</DOC>